Skip to main content

Main menu

  • Home
  • About
    • JALM
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
    • Special Issues & Collections
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Abstracts
  • JALM Talk
  • Submit
  • Feedback
  • Other Publications
    • Clinical Chemistry

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Applied Laboratory Medicine
  • Other Publications
    • Clinical Chemistry
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Applied Laboratory Medicine

Advanced Search

  • Home
  • About
    • JALM
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
    • Special Issues & Collections
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Abstracts
  • JALM Talk
  • Submit
  • Feedback
Brief ReportFocused Report

Proteolytic Digestion of Serum Cardiac Troponin I as Marker of Ischemic Severity

Somaya Zahran, Vivian P. Figueiredo, Michelle M. Graham, Richard Schulz, Peter M. Hwang
DOI: 10.1373/jalm.2017.025254 Published February 2018
Somaya Zahran
Department of Medicine, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vivian P. Figueiredo
Departments of Pediatrics and Pharmacology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle M. Graham
Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Schulz
Departments of Pediatrics and Pharmacology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter M. Hwang
Division of General Internal Medicine, Department of Medicine and Department of Biochemistry, University of Alberta, Edmonton, AB, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: phwang1@ualberta.ca
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The serum troponin assay is the biochemical gold standard for detecting myocardial infarction (MI). A major diagnostic issue is that some believe troponin levels can rise with reversible injury, in the absence of radiologically detectable infarct.

Hypothesis: Because cell death activates intracellular proteases, troponin released by irreversible infarct will be more proteolyzed than that released by milder processes. Our goal was to quantify proteolytic digestion of cardiac troponin I in patients with varying degrees of myocardial injury.

Methods: Serum or plasma samples from 29 patients with cardiac troponin I elevations were analyzed for proteolytic degradation, using 3 different sandwich ELISAs designed to specifically detect the N-terminal, core, or C-terminal regions of cardiac troponin I.

Results: As predicted, the degree of proteolytic digestion increased with increasing severity of injury, as estimated by the total troponin level, and this trend was more pronounced for C-terminal (vs N-terminal) degradation. The highest degree of proteolytic digestion was observed in patients with ST-elevation MI; the least, in type 2 MI (supply–demand ischemia rather than acute thrombus formation).

Conclusions: The proteolytic degradation pattern of cardiac troponin I may be a better indicator of clinically significant MI than total serum troponin level. Distinguishing between intact and degraded forms of troponin may be useful for (a) identifying those patients with clinically significant infarct in need of revascularization, (b) monitoring intracellular proteolysis as a possible target for therapeutic intervention, and (c) providing an impetus for standardizing the epitopes used in the troponin I assay.

  • Received October 5, 2017.
  • Accepted January 19, 2018.
  • © 2018 American Association for Clinical Chemistry
PreviousNext
Back to top

In this issue

The Journal of Applied Laboratory Medicine: 3 (4)
Vol. 3, Issue 4
January 2019
  • Table of Contents
  • About the Cover
  • Index by author
  • Table of Contents (PDF)
  • Cover (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Share
Proteolytic Digestion of Serum Cardiac Troponin I as Marker of Ischemic Severity
Somaya Zahran, Vivian P. Figueiredo, Michelle M. Graham, Richard Schulz, Peter M. Hwang
The Journal of Applied Laboratory Medicine Feb 2018, jalm.2017.025254; DOI: 10.1373/jalm.2017.025254
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Proteolytic Digestion of Serum Cardiac Troponin I as Marker of Ischemic Severity
Somaya Zahran, Vivian P. Figueiredo, Michelle M. Graham, Richard Schulz, Peter M. Hwang
The Journal of Applied Laboratory Medicine Feb 2018, jalm.2017.025254; DOI: 10.1373/jalm.2017.025254

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Multicenter Evaluation of a High-Sensitivity Troponin-I Assay and Verification of an Early Rule-Out Algorithm
  • “Rainbow Draws” in the Emergency Department: Clinical Utility and Staff Perceptions
  • Stabilization of Plasma Glucose: The Use of Newer Technology and Pragmatic Laboratory Practice
Show more Focused Report

Similar Articles

Subjects

  • Cardiac Markers

Navigate

  • Home
  • About
  • Articles
  • Information for Authors
  • Submit

Other Publications

  • Clinical Chemistry
Footer logo

© 2019 American Association for Clinical Chemistry

Powered by HighWire